Daan Van Well

CIK: 0002006414

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)10 (90.9%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (9.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SOPH

SOPHiA GENETICS SA

Officer

Discretionary Trading P&L

Holdings

Transaction History (11 total)

SOPH
SOPHiA GENETICS SA
Oct 5, 2026
Sale(S)
Direct
6.2K shares at avg. $8.12$50K
SOPH
SOPHiA GENETICS SA
Sep 11, 2026
Sale(S)
Direct
6.2K shares at avg. $7.63$47K
SOPH
SOPHiA GENETICS SA
May 19, 2026
Sale(S)
Direct
684 shares at avg. $4.60$3K
SOPH
SOPHiA GENETICS SA
Apr 20, 2026
Sale(S)
Direct
684 shares at avg. $5.20$4K
SOPH
SOPHiA GENETICS SA
Apr 10, 2026
Sale(S)
Direct
2.4K shares at avg. $4.67$11K
SOPH
SOPHiA GENETICS SA
Apr 9, 2026
Sale(S)
Direct
2K shares at avg. $4.74$9K
SOPH
SOPHiA GENETICS SA
Apr 8, 2026
Sale(S)
Direct
2.9K shares at avg. $4.85$14K
SOPH
SOPHiA GENETICS SA
Apr 7, 2026
Sale(S)
Direct
2.4K shares at avg. $4.87$12K
SOPH
SOPHiA GENETICS SA
Apr 6, 2026
Sale(S)
Direct
2.7K shares at avg. $4.86$13K
SOPH
SOPHiA GENETICS SA
Apr 2, 2026
Award(A)
Direct
97.5K shares-
SOPH
SOPHiA GENETICS SA
Mar 19, 2026
Sale(S)
Direct
684 shares at avg. $4.79$3K

		Type	Shares	Price		Ownership
Oct 5, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	6,168	$8.12	$50,100	Direct
Sep 11, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	6,168	$7.63	$47,089	Direct
May 19, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	684	$4.60	$3,149	Direct
Apr 20, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	684	$5.20	$3,554	Direct
Apr 10, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	2,400	$4.67	$11,201	Direct
Apr 9, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	1,988	$4.74	$9,424	Direct
Apr 8, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	2,861	$4.85	$13,862	Direct
Apr 7, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	2,400	$4.87	$11,682	Direct
Apr 6, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	2,705	$4.86	$13,136	Direct
Apr 2, 2026	SOPH SOPHiA GENETICS SA	Award(A)	97,536	-	$0	Direct
Mar 19, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	684	$4.79	$3,274	Direct

1-11 of 11 transactions

About Van Well Daan

Van Well Daan (SEC CIK 0002006414) files insider reports with the SEC as Chief Legal Officer of SOPHiA GENETICS SA (SOPH).

Signal8 holds 11 ownership filings by Van Well Daan (1 Form 3, 10 Form 4), filed between Mar 18, 2026 and Oct 7, 2026. Those filings report 11 transactions, from Mar 19, 2026 to Oct 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Van Well Daan's filings is in ROLLE.

Recent filings by Van Well Daan

Oct 5, 2026: Open-market sale of SOPH shares (Form 4, code S).
Sep 11, 2026: Open-market sale of SOPH shares (Form 4, code S).
May 19, 2026: Open-market sale of SOPH shares (Form 4, code S).
Apr 20, 2026: Open-market sale of SOPH shares (Form 4, code S).
Apr 10, 2026: Open-market sale of SOPH shares (Form 4, code S).

Other insiders filing for SOPHiA GENETICS SA (SOPH)

Menu Philippe, Chief Medical Officer
Xu Zhenyu, Chief Scientific Officer
Camblong Jurgi, Executive Chairman
Valente Manuela, Chief People Officer
Verma Abhimanyu, Chief Technology Officer
Puylaert Kevin, Chief Sales Officer

How to read Form 4 transaction codes